HighTide Therapeutics, Inc. (HKG:2511)
Hong Kong · Delayed Price · Currency is HKD 3.300
+0.175 (5.60%)
Sep 18, 2026, 3:55 PM HKT
HighTide Therapeutics Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Selling, General & Admin | 80.97 | 59.1 | 81.23 | 136.67 | 43.43 | 48.06 |
Research & Development | 94.88 | 164.47 | 363.53 | 311.57 | 182.65 | 84.01 |
Operating Expenses | 175.86 | 223.57 | 444.75 | 448.24 | 226.08 | 132.08 |
Operating Income | -175.86 | -223.57 | -444.75 | -448.24 | -226.08 | -132.08 |
Interest Expense | -4.05 | -2.36 | -1.53 | -0.4 | -0.43 | -4.53 |
Interest & Investment Income | 8.07 | 10.5 | 29.18 | 24.28 | 12.38 | 3.33 |
Currency Exchange Gain (Loss) | -0.31 | -0.04 | 3.12 | -0.89 | -7.52 | 0.6 |
Other Non Operating Income (Expenses) | 3.7 | 8.51 | 38.79 | 8.17 | 8.2 | 5.28 |
EBT Excluding Unusual Items | -168.45 | -206.97 | -375.2 | -417.07 | -213.45 | -127.39 |
Gain (Loss) on Sale of Investments | -116.92 | -24.87 | -6.11 | - | - | - |
Gain (Loss) on Sale of Assets | -0.06 | -0.05 | -0.21 | - | - | -0 |
Other Unusual Items | 0.12 | - | - | -522.16 | 23.24 | -93.66 |
Pretax Income | -285.3 | -231.88 | -381.52 | -939.23 | -190.21 | -221.05 |
Income Tax Expense | 0.21 | 0.22 | 0.27 | 0.08 | 0.03 | 0.1 |
Earnings From Continuing Operations | -285.51 | -232.1 | -381.79 | -939.31 | -190.24 | -221.15 |
Minority Interest in Earnings | 14.77 | -12.87 | - | - | - | - |
Net Income | -270.75 | -244.97 | -381.79 | -939.31 | -190.24 | -221.15 |
Net Income to Common | -270.75 | -244.97 | -381.79 | -939.31 | -190.24 | -221.15 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 508 | 480 | 452 | 260 | 255 | 42 |
Shares Outstanding (Diluted) | 508 | 480 | 452 | 260 | 255 | 42 |
Shares Change | 12.36% | 6.12% | 74.08% | 1.91% | 506.17% | - |
EPS (Basic) | -0.53 | -0.51 | -0.84 | -3.62 | -0.75 | -5.26 |
EPS (Diluted) | -0.53 | -0.51 | -0.84 | -3.62 | -0.75 | -5.26 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | -166.98 | -302.75 | -357.42 | -172.56 | -92.29 |
Free Cash Flow Per Share | - | -0.35 | -0.67 | -1.38 | -0.68 | -2.19 |
EBITDA | -174.49 | -222.16 | -443.75 | -447.7 | -225.68 | -131.8 |
D&A For EBITDA | 1.37 | 1.41 | 1.01 | 0.54 | 0.41 | 0.28 |
EBIT | -175.86 | -223.57 | -444.75 | -448.24 | -226.08 | -132.08 |